Schlagwort: Artificial Intelligence
AI in Drug Development: Where Value is Emerging
The pharmaceutical industry is defined by well-known metrics: decade-long development timelines, billion-dollar costs, high failure rates. Against this backdrop, AI promises to make drug...
‘‘We build a leading global platform for precision healthcare‘‘
Leo International Precision Health AG (LIPH) is an investment holding company (WKN: 549060; ticker: LEOW) that has been listed on the stock exchange since...
Protecting Innovation: Intellectual Property Insurance – the Emerging Essential
In a global, innovation-driven economy, intangible assets such as patents, trademarks, and know-how often account for half or more of a company’s value. In...
Are European Life Sciences Startups in Trouble?
Investment in the life sciences sector is facing challenges, with fewer deals and increasing market uncertainty. Despite these difficulties, however, investment volumes are on...
Out now! Special „Corporate Finance Recht 2024“
Im Februar 2024 haben sich die Mitgliedstaaten und das EU-Parlament auf den EU Listing Act geeinigt, dessen Ziel es ist, die Attraktivität der Börsennotiz...
Curious2024 – Future Insight™️ conference
Join us at the Curious – Future Insight™️ Conference 2024, one of the world's leading gatherings on the future of science & technology, happening...
The potential of AI in drug discovery
Tools and methods derived from artificial intelligence (AI) will revolutionize drug discovery processes by identifying novel molecular targets, increasing the probability of success in...
Was Künstliche Intelligenz im M&A-Geschäft bringt
KI-Tools und Large Language Models (LLMs) werden bereits als Teil von Standardsoftwarelösungen eingesetzt. ChatGPT und andere LLMs können nicht länger als bloßes „Nice-to-have“ angesehen...
Predicting clinical trial success and improving R&D
A major theme for biopharma companies is the low rate of success in drug R&D, from early R&D through clinical development and regulatory approval....
Blueprint Genetics wirbt 14 Mio. EUR ein
Ein internationales Konsortium um die Lead-Investoren Creathor Venture und MedTech Innovation Partners beteiligt sich zusammen mit den bestehenden Investoren Inventure und Pontos Group im...